Overview

Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Interaction of GLP-1 and PYY3-36 in the inhibition of food intake in healthy subjects
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Glucagon-Like Peptide 1